Kairos Pharma KAPA
NYSE KAPA
$0.56 -0.02 (-3.12%)
As of: Oct 22, 2026 · 11:37 AM EDT

Kairos Pharma (KAPA) Times Interest Earned (2023 - 2024)

Updated

Kairos Pharma's Times Interest Earned came in at -66.94 for FY2024, compared with -40.81 in FY2023.

Analysis

Kairos Pharma (KAPA) Times Interest Earned (2023 - 2024) Analysis & Trends

  • Per Business Quant, earlier years put Times Interest Earned at -40.81 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,170.64 Bn 1,139.22 Bn 19.71 Bn -
2 Johnson & Johnson 640.54 Bn 559.06 Bn 17.26 Bn 25.41
3 AbbVie 501.78 Bn 474.89 Bn 12.70 Bn -
4 Merck 374.95 Bn 329.32 Bn 12.21 Bn -
5 Novartis Ag 302.43 Bn 266.42 Bn 11.24 Bn 10.28
6 Astrazeneca 268.31 Bn 241.99 Bn 12.86 Bn 7.27
7 Amgen 242.70 Bn 198.10 Bn 7.24 Bn 5.22
8 Gilead Sciences 193.64 Bn 167.84 Bn 6.22 Bn -42.08
9 Pfizer 172.34 Bn 118.98 Bn 10.94 Bn -
10 Kairos Pharma 10.29 Mn -2.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -31.92
Jun 30, 2024 -18.50
Mar 31, 2024 -17.94
Dec 31, 2023 -363.00
Sep 30, 2023 -19.13
API Access

Kairos Pharma Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=KAPA&period=max&api_key=YOUR_API_KEY